HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,218,827 | -3.3% | 716,888 | -8.1% | 0.02% | 0.0% |
| Q2 2023 | $66,425,632 | +115.4% | 780,193 | +109.3% | 0.02% | +88.9% |
| Q1 2023 | $30,844,897 | +227.2% | 372,748 | +211.0% | 0.01% | +200.0% |
| Q4 2022 | $9,425,574 | +12.8% | 119,842 | +6.2% | 0.00% | 0.0% |
| Q3 2022 | $8,353,000 | +23.7% | 112,844 | +8.9% | 0.00% | +50.0% |
| Q2 2022 | $6,753,000 | +12.9% | 103,605 | +9.5% | 0.00% | 0.0% |
| Q1 2022 | $5,981,000 | +50.5% | 94,626 | +26.3% | 0.00% | +100.0% |
| Q4 2021 | $3,973,000 | -23.8% | 74,915 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $5,212,000 | +3.7% | 73,828 | -2.1% | 0.00% | 0.0% |
| Q2 2021 | $5,026,000 | -77.1% | 75,430 | -61.9% | 0.00% | -83.3% |
| Q1 2021 | $21,992,000 | +0.9% | 198,102 | +7.9% | 0.01% | 0.0% |
| Q4 2020 | $21,806,000 | +67.1% | 183,625 | +22.8% | 0.01% | +50.0% |
| Q3 2020 | $13,047,000 | -60.3% | 149,532 | -59.2% | 0.00% | -66.7% |
| Q2 2020 | $32,863,000 | -60.9% | 366,939 | -56.5% | 0.01% | -65.7% |
| Q1 2020 | $84,108,000 | +2.2% | 843,946 | +17.8% | 0.04% | +34.6% |
| Q4 2019 | $82,320,000 | -14.5% | 716,444 | -6.1% | 0.03% | +4.0% |
| Q3 2019 | $96,260,000 | +83.6% | 763,120 | +75.2% | 0.02% | +92.3% |
| Q2 2019 | $52,419,000 | +1001.7% | 435,592 | +700.8% | 0.01% | +550.0% |
| Q1 2019 | $4,758,000 | -80.9% | 54,396 | -78.2% | 0.00% | -80.0% |
| Q4 2018 | $24,935,000 | +14.3% | 249,226 | +30.9% | 0.01% | +42.9% |
| Q3 2018 | $21,820,000 | +46.2% | 190,426 | +14.4% | 0.01% | +40.0% |
| Q2 2018 | $14,929,000 | -40.3% | 166,456 | -51.3% | 0.01% | -44.4% |
| Q1 2018 | $25,000,000 | +19.0% | 341,708 | -5.5% | 0.01% | +12.5% |
| Q4 2017 | $21,012,000 | +164.0% | 361,769 | +104.0% | 0.01% | +166.7% |
| Q3 2017 | $7,959,000 | +14.3% | 177,374 | +0.6% | 0.00% | +50.0% |
| Q2 2017 | $6,966,000 | +5.1% | 176,398 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $6,628,000 | +2.7% | 163,379 | +1.7% | 0.00% | 0.0% |
| Q4 2016 | $6,455,000 | +3.4% | 160,583 | -6.9% | 0.00% | 0.0% |
| Q3 2016 | $6,243,000 | -26.8% | 172,423 | -41.4% | 0.00% | -33.3% |
| Q2 2016 | $8,532,000 | +1.0% | 294,295 | +21.9% | 0.00% | 0.0% |
| Q1 2016 | $8,446,000 | +30.5% | 241,447 | +20.3% | 0.00% | 0.0% |
| Q4 2015 | $6,470,000 | +4.9% | 200,696 | +5.2% | 0.00% | 0.0% |
| Q3 2015 | $6,167,000 | -58.8% | 190,813 | -47.2% | 0.00% | -50.0% |
| Q2 2015 | $14,957,000 | -52.3% | 361,626 | -48.1% | 0.01% | -50.0% |
| Q1 2015 | $31,327,000 | +19.9% | 697,425 | -0.1% | 0.01% | +20.0% |
| Q4 2014 | $26,118,000 | +2.2% | 697,985 | -4.6% | 0.01% | 0.0% |
| Q3 2014 | $25,548,000 | -3.2% | 731,609 | -2.2% | 0.01% | 0.0% |
| Q2 2014 | $26,379,000 | +6.1% | 747,685 | -2.0% | 0.01% | 0.0% |
| Q1 2014 | $24,866,000 | -21.6% | 762,976 | +1.3% | 0.01% | -23.1% |
| Q4 2013 | $31,716,000 | +9.2% | 752,832 | +3.4% | 0.01% | 0.0% |
| Q3 2013 | $29,033,000 | +2.8% | 728,016 | +6.5% | 0.01% | 0.0% |
| Q2 2013 | $28,254,000 | – | 683,289 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |